Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis

Journal of Travel Medicine

Volumn 13, Issue 6, 2006, Pages 373-375

  Jiménez, Beatriz C ^a   Navarro, Miriam ^a   Huerga, Helena ^a   López Román, Eva ^b   Mendoza, Alfonso ^b   López Vélez, Rogelio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PRIMAQUINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LIVER FUNCTION TEST; MALARIA; MALE; PARASITE IDENTIFICATION; PLASMODIUM OVALE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM OVALE; PLASMODIUM VIVAX; TRAVEL;

EID: 33750863995     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00073.x     Document Type: Article

References (10)

1. Schwartz E, Parise M, Korzarsky P, Cetron M. Delayed onset of malaria - implications for chemoprophylaxis in travelers. N Engl J Med. 2003; 349:1510-1516.
2. Hogh B, Clarke PD, Camus D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double blind study. Malarone International Study team. Lancet 2000; 356:1888-1894.
3. Looareesuwan S, Wilairatana P, Glanarongan M, et al. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Trans R Soc Trop Med Hyg 1999; 93:637-640.
4. Povinelli L, Monson TA, Fox BC, et al. Plasmodium vivax malaria in spite of atovaquone/proguanil (Malarone) prophylaxis. J Travel Med 2003; 10:353-355.
5. Kofoed K, Petersen E. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine and atovaquone plus proguanil in travelers from Denmark. J Travel Med 2003; 10:150-154.
6. Rubio JM, Benito A, Berzosa PJ, et al. Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain. J Clin Microbiol 1999; 37:3260-3264.
7. Patel SN, Kain KC. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Expert Rev Anti Infect Ther 2005; 3:849-861.
8. Berman JD, Nielsen R, Chulay, JD et al. Causal prophylactic efficacy of atovaquone-proguanil (Malarone™) in a human challenge model. Trans R Soc Trop Med Hyg 2001; 95:429-432.
9. Ling J, Baird JK, Fryauff DJ, et al. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Clin Infect Dis 2002; 35:825-833.
10. Lacy MD, Maguire JD, Barcus MJ, et al. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Clin Infect Dis 2002; 35:e92-e95.